Last reviewed · How we verify
NCT06117943: tabac-GO
Pregnant Women's Knowledge of the Active and Passive Smoking Effects on Pregnancy and the Fetus
trial testing data collection in Pregnant Women's Tabacco Exposure in 500 participants. Status unknown.
1 February 2024
Quick facts
| Lead sponsor | Université de Reims Champagne-Ardenne |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 December 2023 |
| Primary completion | 1 February 2024 |
| Estimated completion | 1 May 2024 |
| Sites | 2 locations across France |
Drugs / interventions tested
- data collection — full drug profile →
Conditions studied
- Pregnant Women's Tabacco Exposure — all drugs for Pregnant Women's Tabacco Exposure →
Sponsor
Université de Reims Champagne-Ardenne
Who can join
18 and older, female only, with Pregnant Women's Tabacco Exposure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There are two remaining areas where the standards for tobacco use during pregnancy have changed little: one area is the high level of consumption by pregnant women and the other is the limited care given to pregnant women. Indeed, many pregnant women are still over-exposed to tobacco, either through personal use or passive exposure to cigarette smoke. This passive exposure often comes from the consumption of their loved ones, such as their future co-parent or family. However, throughout our lives, health professionals, associations, and the government send a lot of information and messages about the negative effects of tobacco on health, pregnancy, and the fetus. This information and the possibility of receiving help from a professional trained in tobacco use exist throughout the entire pregnancy. However, many women and their partners still do not take the necessary precautions to reduce or stop smoking. Do couples who smoke during pregnancy really have an understanding of the smoking's effects on women and their fetuses? Could they realize it and would they reduce or stop their consumption, in case they knew these negative effects?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06117943
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of data collection
Trials testing the same drug.
- NCT07437495 — Women's Knowledge of Contraception During the Postpartum Period · active not recruiting
- NCT07424937 — Prevalence of Regular Gynecological Follow-up Among Women of Childbearing Age · completed
- NCT07440082 — Resumption of Sexual Intercourse in the Postpartum Period: Women's Experiences · completed
- NCT07241299 — Understanding Chronic Treatments by Patients Over 65 Years of Age · recruiting
- NCT07338955 — Validating and Assessing Reliability · recruiting
Other Université de Reims Champagne-Ardenne trials
Trials by the same sponsor.
- NCT07437495 — Women's Knowledge of Contraception During the Postpartum Period · active not recruiting
- NCT07418359 — Comparison of Patient's Physical Activity Levels According to the Physical Activity Level of Their General Practitioner · recruiting
- NCT07424937 — Prevalence of Regular Gynecological Follow-up Among Women of Childbearing Age · completed
- NCT07440082 — Resumption of Sexual Intercourse in the Postpartum Period: Women's Experiences · completed
- NCT07241299 — Understanding Chronic Treatments by Patients Over 65 Years of Age · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06117943 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Université de Reims Champagne-Ardenne
- Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06117943.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing